Subjective health status in men and women with congenital adrenal hyperplasia: A population-based survey in Norway

European Journal of Endocrinology

Volumn 163, Issue 3, 2010, Pages 453-459

  Nermoen, Ingrid ^a   Husebye, Eystein S ^b,c   Svartberg, Johan ^d,e   Løvås, Kristian ^b,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; DISABILITY; DRUG COMBINATION; FEMALE; HEALTH STATUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENSTRUAL IRREGULARITY; MENTAL HEALTH; NORWAY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SOCIAL INTERACTION; UNIVERSITY HOSPITAL;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS; HUMANS; INFERTILITY, FEMALE; MALE; MIDDLE AGED; NORWAY; POPULATION SURVEILLANCE; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 77956272026     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0284     Document Type: Article

References (36)

1. White PC & Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews 2000 21 245-291. (Pubitemid 32275589)
2. Pang S. Newborn screening for congenital adrenal hyperplasia. Pediatric Annals 2003 32 516-523. (Pubitemid 36962518)
3. Merke DP. Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 2008 93 653-660. (Pubitemid 351398534)
4. Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, Darzy K, Merke DP, Arlt W & Ross RJ. Modified-release hydrocortisone to provide circadian cortisol profiles. Journal of Clinical Endocrinology and Metabolism 2009 94 1548-1554.
5. Bryan SM, Honour JW & Hindmarsh PC. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. Journal of Clinical Endocrinology and Metabolism 2009 94 3477-3480.
6. Løvås K & Husebye ES. Continuous subcutaneous hydrocortisone infusion in Addison's disease. European Journal of Endocrinology 2007 157 109-112. (Pubitemid 47162573)
7. Berenbaum SA & Bailey JM. Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2003 88 1102-1106.
8. Berenbaum SA, Korman BK, Duck SC & Resnick SM. Psychological adjustment in children and adults with congenital adrenal hyperplasia. Journal of Pediatrics 2004 144 741-746. (Pubitemid 38858090)
9. Ehrhardt AA, Epstein R & Money J. Fetal androgens and female gender identity in the early-treated adrenogenital syndrome. Johns Hopkins Medical Journal 1968 122 160-167.
10. Frisen L, Nordenstrom A, Falhammar H, Filipsson H, Holmdahl G, Janson PO, Thoren M, Hagenfeldt K, Moller A & Nordenskjold A. Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. Journal of Clinical Endocrinology and Metabolism 2009 94 3432-3439.
11. Jaaskelainen J & Voutilainen R. Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatrica 2000 89 183-187.
12. Kuhnle U, Bullinger M & Schwarz HP. The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. European Journal of Pediatrics 1995 154 708-716. (Pubitemid 26231585)
13. Eugster EA, Dimeglio LA,Wright JC, Freidenberg GR, Seshadri R & Pescovitz OH. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. Journal of Pediatrics 2001 138 26-32. (Pubitemid 32097137)
14. Hagenfeldt K, Janson PO, Holmdahl G, Falhammar H, Filipsson H, Frisen L, Thoren M & Nordenskjold A. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Reproduction 2008 23 1607-1613. (Pubitemid 351809706)
15. Ware JE, Snow KK, Kosinski M & Gandek B. SF-36® Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993.
16. Loge JH & Kaasa S. Short Form 36 (SF-36) health survey: normative data from the general Norwegian population. Scandinavian Journal of Public Health 1998 26 250-258. (Pubitemid 128671032)
17. Ware JE & Sherbourne CD. The MOS 36-item short-form health survey (SF-36). 1. Conceptual-framework and item selection. Medical Care 1992 30 473-483.
18. Burckhardt CS & Anderson KL. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health and Quality of Life Outcomes 2003 1 60.
19. Wahl A, Burckhardt C,Wiklund I & Hanestad BR. The Norwegian version of the Quality of Life Scale (QOLS-N). A validation and reliability study in patients suffering from psoriasis. Scandinavian Journal of Caring Sciences 1998 12 215-222. (Pubitemid 29006158)
20. Wahl AK, Rustoen T, Hanestad BR, Lerdal A & Moum T. Quality of life in the general Norwegian population, measured by the Quality of Life Scale (QOLS-N). Quality of Life Research 2004 13 1001-1009. (Pubitemid 39005109)
21. Thil'en A, Nordenstrom A, Hagenfeldt L, von Dobeln U, Guthenberg C & Larsson A. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics 1998 101 4-11.
22. NordenstromA, Ahmed S, Jones J, Coleman M, Price DA, Clayton PE & Hall CM. Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening. Hormone Research 2005 63 22-28.
23. Thilen A & Larsson A. Congenital adrenal-hyperplasia in Sweden 1969-1986 - prevalence, symptoms and age at diagnosis. Acta Paediatrica Scandinavica 1990 79 168-175.
24. Nermoen I, Folling I, Vegge K, Larmo A, Nedrebo BG, Husebye ES & Løvås K. Two adults with adrenal myelolipoma and 21-hydroxylase deficiency. Case Reports in Medicine 2009 2009 Article ID 916891. DOI:10.1155/2009/916891.
25. Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H & Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian Registry. Journal of Clinical Endocrinology and Metabolism 2009 95 4882-4890.
26. Liang HY, Chang HL, Chen CY, Chang PY, Lo FS & Lee LW. Psychiatric manifestations in young females with congenital adrenal hyperplasia in Taiwan. Chang Gung Medical Journal 2008 31 66-73.
27. Johannsen TH, Ripa CP, Mortensen EL & Main KM. Quality of life in 70 women with disorders of sex development. European Journal of Endocrinology 2006 155 877-885. (Pubitemid 46040627)
28. Nordenskjold A, Holmdahl G, Frisen L, Falhammar H, Filipsson H, Thoren M, Janson PO & Hagenfeldt K. Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2008 93 380-386. (Pubitemid 351240807)
29. van Rijn T. A physiatrist's view of response shift. Journal of Clinical Epidemiology 2009 62 1191-1195.
30. Løvås K, Loge JH & Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clinical Endocrinology 2002 56 581-588. (Pubitemid 34595724)
31. Mulaikal RM, Migeon CJ & Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. New England Journal of Medicine 1987 316 178-182. (Pubitemid 17052760)
32. Reisch N, Flade L, Scherr M, Rottenkolber M, Pedrosa GF, Bidlingmaier M, Wolff H, Schwarz HP, Quinkler M, Beuschlein F & Reincke M. High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2009 94 1665-1670.
33. Claahsen-van der Grinten HL, Otten BJ, Stikkelbroeck MM, Sweep FC & Hermus AR. Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Practice and Research. Clinical Endocrinology and Metabolism 2009 23 209-220.
34. Urban MD, Lee PA & Migeon CJ. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. New England Journal of Medicine 1978 299 1392-1396. (Pubitemid 9092482)
35. Jaaskelainen J, Kiekara O, Hippelainen M & Voutilainen R. Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency. Journal of Endocrinological Investigation 2000 23 23-27. (Pubitemid 30105315)
36. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjold A, Hagenfeldt K & Thoren M. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 2007 92 110-116. (Pubitemid 46067517)